Outlook Therapeutics News, Outlook Therapeutics Quote, OTLK Quote

Outlook Therapeutics (NQ:OTLK) Delayed: 1.58 -0.07 (4.24%)

Prev. Close

$1.65

Today 6M 1Y 5Y

Open

$1.62

52 Wk High

$0.03

52 Wk Low

$0.01

Day High

$1.66

Day Low

$1.40

P/E

N/A

EPS

$0.00

Volume

20,623,167

Friends, Peers and Foes (?): OTLKW, AKTX, AMIX, CNSP, GRI (more...)

ALERTS | RSS

Jun 17, 2026 06:49 AM Increasing unusual call option volume: OTLK EWJ AMPG LION MGNI TENB FSK CXW LASE
Jun 16, 2026 08:46 AM Form 8-K Outlook Therapeutics, For: Jun 16
Jun 16, 2026 08:02 AM FDA accepts OUTLOOK THERAPEUTICS BLA resubmission for wet AMD drug
Jun 16, 2026 08:02 AM Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD
Jun 3, 2026 06:03 PM Form 4 Outlook Therapeutics, For: Jun 02 Filed by: Haddadin Yezan Munther
Jun 1, 2026 09:31 PM Form SCHEDULE 13D/A Outlook Therapeutics, Filed by: GMS Ventures & Investments
Jun 1, 2026 09:30 PM Form 4 Outlook Therapeutics, For: May 28 Filed by: Sukhtian Ghiath M.
Jun 1, 2026 05:02 PM Form DEFA14A Outlook Therapeutics,
Jun 1, 2026 05:00 PM Form DEF 14A Outlook Therapeutics, For: Jul 16
Jun 1, 2026 09:15 AM Form 8-K Outlook Therapeutics, For: Jun 01

Entities mentioned with OTLK

View All Entities